MicroRNA-155 Function in B Cells  by Calame, Kathryn
Immunity
PreviewsMicroRNA-155 Function in B Cells
Kathryn Calame1,*
1Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
*Correspondence: klc1@columbia.edu
DOI 10.1016/j.immuni.2007.11.010
Vigorito et al. (2007) report (in this issue of Immunity) that B cells require microRNA (miR)-155 for
normal production of isotype-switched, high-affinity antibodies and for a memory response. They
identify transcriptional regulator Pu.1 as a functionally important target of miR-155 in B cells.MiR-155 is encoded within a region
known as bic,B cell integration cluster,
identified originally as a frequent inte-
gration site for avian leucosis virus (La-
gos-Quintana et al., 2002; Tam et al.,
1997). An important role for miR-155
in B cell malignancies was strongly
suggested by the observations that
miR-155 is elevated in certain B cell
lymphomas (Eis et al., 2005) and that
transgenic expression of miR-155 in
B cells causes pre-B cell lymphomas
in mice (Costinean et al., 2006). Fur-
thermore, the expression pattern of
miR-155 in normal B cells suggests
a role in differentiation of normal acti-
vated B cells because it is induced
upon B cell receptor (BCR) ligation of
Ramos cells (van den Berg et al.,
2003).
Earlier this year, Rodriguez et al.
(2007) and Thai et al. (2007) simulta-
neously reported that mice harboring
a germline deletion of miR-155 have
normal lymphocyte development but
defective T and B immunity, including
reduced numbers of germinal center
(GC) B cells. However, the cellular
nature of these defects was not iden-
tified. In the current work, the B cell-in-
trinsic defects caused by the absence
of miR-155 were identified by analysis
of purified B cells activated in vitro and
chimeric mice in which only B cells
lacked miR-155.
Immunization of miR-155-deficient
mice with either the T cell independent
(TI) antigen DNP-LPS (dinitropheny-
lated lipopolysaccharide) or with the
T cell dependent (TD) antigen NP-
KLH (4-hydroxy 3-nitrophenylacetyl
keyhole limpet hemocyanin) gave sim-
ilar results in that IgM responses were
normal, but IgG1 responses were sub-
stantially reduced in the miR-155-defi-cient mice, suggesting a particular
defect related to formation or main-
tenance of plasma cells secreting
switched isotypes.
TI and TD responses are different in
several ways (Figure 1). TI antigens pri-
marily activate marginal zone and B-1
B cells via BCR and Toll-like receptor
(TLR) signaling, whereas TD antigens
primarily activate follicular B cells in re-
sponse to BCR, TLR, T cell cytokines,
and CD40 signaling. Although both re-
sponses cause an extrafollicular, early
burst of short-lived plasma cells pro-
ducing low-affinity antibody, the TD re-
sponse also leads to the formation of
GCs, reviewed recently by Allen et al.
(2007). In GCs, B cells undergo intense
proliferation, somatic hypermutation
(SHM) of the rearranged Ig variable
gene segments, and class switch re-
combination (CSR). Selection, involv-
ing competition both for antigen and
for T cell help, then provides survival
signals for clones making high-affinity
BCR, whereas clones with lower-affin-
ity BCR or clones unable to obtain
T cell help die by apoptosis. This se-
lective pressure, combined with ongo-
ing somatic mutation of Ig V gene seg-
ments, results in ‘‘affinity maturation’’
of GC B cells. Surviving GC B cell
clones can either undergo further
rounds of proliferation, SHM, CSR,
and selection or differentiate and leave
theGC. B cells leaving theGCdifferen-
tiate into plasma cells, which can mi-
grate to survival niches in the bone
marrow or into memory B cells. Ex-
pression of high-affinity, switched-iso-
type immunoglobulin is characteristic
of plasma cells and memory cells re-
sulting for a GC reaction.
In miR-155-deficient mice, the ex-
trafollicular response to both TI andImmunity 27,TD antigens was defective for
switched isotypes, but not for IgM (Fig-
ure 1). In addition, the number of anti-
body-secreting cells formed in an ex-
trafollicular response was decreased,
although secretion on a per-cell basis
was normal, suggesting that formation
or maintenance of plasma cells might
be defective but that plasma cells dif-
ferentiated into Ig-secreting cells nor-
mally. Multiple defects were observed
in the GC response (Figure 1) including
decreased numbers of GC B cells, de-
creased IgG production, decreased
affinity maturation, decreased num-
bers of memory cells, a reduced mem-
ory response, and decreased IgG1
plasma cells in the bone marrow.
When the authors explored the
mechanisms of these defects, the re-
sults were surprising. The miR-155
Bcells did not havedefects in prolifera-
tion, at least as measured in in vitro
cultures stimulated with LPS or CD40
and cytokines. Because the antiapo-
ptotic protein Bcl-2 can rescue B cells
from apoptosis, the possibility of in-
creased apoptosis in the miR-155-de-
ficient B cells was explored by forced
expression of Bcl-2 in in vitro cultures
of B cells lacking miR-155. However,
this did not alter the reduced numbers
of IgG1+ cells in miR-155 B cell cul-
tures, suggesting the defects were
not due to increased apoptosis. Acti-
vation-induced cytidine deaminase
(AID) is required for both SHM and
CSR; however, AID mRNA expression
was comparable in wild-type and
miR-155-deficient B cells. Consistent
with this finding, analysis of mutation
in a noncoding VH region not subject
to selection showed that the wild-
type and miR-155-deficient B cells
had a nearly comparable frequencyDecember 2007 ª2007 Elsevier Inc. 825
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The important steps in TI and TD B cell responses are summarized above the horizontal line.
Processes that might be defective in miR-155-deficient B cells are indicated in blue. Below the
horizontal line, the defects observed by Vigorito et al. (2007) in miR-155-deficient B cells are
summarized.and a similar pattern of mutation, sug-
gesting that the SHM mechanisms
were intact in miR-155-deficient ani-
mals. Finally, the germline transcripts
that are required prior to CSR and the
switch circle transcripts that result
from CSR were present in normal
amounts in the miR-155-deficient
B cells, showing that the CSR mecha-
nisms were intact.
How can we account for these ob-
servations? The authors suggest the
reasonable conclusion that selection
is defective for the GC B cells of the
miR-155-deficient mice. Selection of
B cells requires robust expression
and function of BCR, MHC class II,
CD80, CD86, CD40, complement, Fc,
and cytokine receptors so that the
B cell can respond to antigen, process
and present antigen to T cells, stimu-
late T cells, and respond to T cells.
GC B cells also need to control DNA
damage responses. Furthermore, re-
cent studies on the dynamic motions826 Immunity 27, December 2007 ª2007of GC B cells suggest that B migration
to encounter antigen and T cells is crit-
ical (Allen et al., 2007). Thus, B cells
lacking miR-155 might have defects
in any of these mechanisms.
One possible molecular mechanism
for howmiR-155 is working in B cells is
by targeting the ets-family transcrip-
tional regulator Pu.1. This paper pro-
vides strong evidence that mRNA en-
coding Pu.1 is one target of miR-155.
The authors not only show that Pu.1
mRNA is elevated inmiR-155-deficient
B cells but they also show that miR-
155 directly targets Pu.1 mRNA via
a predicted miR-155-binding site in
the 30 untranslated region in a bind-
ing-site-dependent way. Finally, they
show that forced expression of Pu.1
in cultured wild-type primary B cells
recapitulates the miR-155-deficient
defect in IgG1 production. Pu.1 is
known to be important for early B
cell commitment and development;
amounts of it are high in GC B cells,Elsevier Inc.but are reduced upon plasmacytic dif-
ferentiation (Singh et al., 2007). The
current observations provide a basis
for seeking Pu.1 target genes, and
the discovery of these genes might ex-
plain some of the observed B cell de-
fects in the miR-155-deficient mice.
In addition, as the authors discuss,
Pu.1 might not be the only important
target of miR-155 in B cells. The
gene-profiling studies the authors car-
ried out identified 60 genes that are
elevated in B cells of themiR-155-defi-
cientmice and that have potential miR-
155-binding sites in their 30 regions.
Future work to verify those directly tar-
get bymiR-155 and functionally impor-
tant in B cells should yield interesting
results. Furthermore, because micro-
RNAs decrease gene expression by
inhibiting mRNA translation as well
as targeting mRNAs for degradation,
some targets might not have been
revealed by the microarray studies.
Important mechanistic questions
that deserve investigation remain. Why
is there a reduction in the number of
both extrafollicular plasma cells and
GC B cells? The observations that nei-
ther B cell proliferation nor apoptosis
were defective in vitro seem contradic-
tory with decreased cell numbers
in vivo. However, proliferation mea-
sured in vitro might not adequately re-
flect proliferation in vivo, and it is possi-
ble that decreased proliferation could
indeed be associated with loss of
miR-155. Furthermore, there could be
abnormalities that cannot be remedied
by overexpression of Bcl-2 in vitro in
cell death. Another question raised is
whether there can be normal amounts
of germline gamma 1 transcripts and
switch circles but decreased numbers
of IgG1+ cells. Additionally, why are
IgM responses normal, whereas IgG
responses are defective, and why
are switched-isotype plasma cells spe-
cifically reduced? Answers to these
questions might reveal a previously un-
known regulatorystep in theexpression
or function of BCRs of the gamma iso-
type for PC maintenance. Finally, does
the reduction of both post-GC plasma
cells and memory cells suggest regula-
tion at a commonprecursor before final
differentiation occurs in the GC?
MicroRNAs are an exciting new
class of regulators. This work is
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provides about the role of miR-155 in
B lymphocytes. In addition, the work
is also intriguing because the defects
in B cells lacking miR-155, although
currently not fully clarified at either
the functional or molecular level, are
quite unusual. Thus, the phenotype
of miR-155-deficient B cells might
ultimately provide new insights into
regulation of poorly understood steps
in B cell differentiation, including se-
lection of high-affinity clones during
the germinal-center reaction, memory
cell formation, and putative differ-
ences in homeostasis of plasma cell
clones expressing B cell receptors of
different isotypes. In addition, it is im-
portant to remember that miR-155 is
also involved in B cell malignancies.E Proteins Enforc
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In this issue of Immunity, two st
Agata et al. (2007) show a new ro
in positive selection.
The four E proteins (E12, E47, E2-2,
and HEB) are widely expressed basic
helix-loop-helix proteins that bind to
a canonical site (CANNTG) in DNA as
homo- and heterodimers, where they
can either activate or repress gene ex-
pression. The E12 and E47 molecules
were originally identified as proteins
that could bind to the immunoglobulin
enhancer, and E12 and E47 are splice
variants of a single gene (Tcfe2a) that
is a common breakpoint in B cell acute
lymphoblastic leukemia translocations
(Mellentin et al., 1989). Consistent with
these observations, deletion of Tcfe2a
in mice by gene targeting results in
a complete block early in B cell devel-Hopefully, further mechanistic studies
in miR-155-deficient B cells will also
provide novel insights into B cell lym-
phomagenesis.
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motes Tcrg and Tcrd gene rearrange-
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role in maintaining the phenotype of
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mocyte development. Development
beyond the DN3 stage requires ex-
pression of a pre-T cell receptor (pre-
TCR), composed of the invariant pre-
Ta chain and the rearranged TCRb
chain. Thus, development beyond the
DN3 stage requires successful re-
arrangement of TCRb (b selection).
Once the pre-TCR is formed, the DN3
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